tocilizumab: car-t cell therapy in dlbcl
Published 3 years ago • 541 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
2:18
tocilizumab: car t-cell therapy in dlbcl
-
6:07
managing crs in car t-cell therapy
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
2:30
the future of car t-cell therapy
-
3:55
side effects of car t-cell therapy and their management
-
2:05
the cost-effectiveness of car t-cell therapy
-
4:10
car t-cell therapy for all
-
2:42
siltuximab for first-line treatment of crs in patients receiving car-t therapy
-
11:17
car-t cells: engineered cancer killers
-
11:34
chimeric antigen receptor car technique - creative biolabs (updated version)
-
3:14
car t-cell therapy explained (manufacturing process & how it works)
-
1:31
tocilizumab for car-t adverse event management
-
2:29
bringing car t-cell therapy to the mainstream
-
7:36
star t-cell therapy for r/r b-cell all
-
1:32
car t-cell therapy: the importance of ltfu
-
2:10
car t-cell therapy video
-
2:11
cytokine release syndrome in car t-cell therapy
-
1:27
car t-cells in all: an overview
-
3:04
car t-cell therapy for b-cell lymphomas: a focus on improving cr
-
1:31
strategies to minimize the occurrence of crs and icans in patients treated with car-t therapy
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
3:57
mechanisms and management of short- and long-term car-t toxicities